Defective Pricing & the False Claims Act
Client Alert | 1 min read | 05.21.19
The enactments of the False Claim Act (FCA) and the Truth in Negotiations Act (TINA) were separated by nearly 100 years, yet the two statutes have become kissing cousins, with many defective pricing cases turning into fraud actions. In Defective Pricing & the False Claims Act, published in the April 2019 issue of Thomson Reuters’s Briefing Papers, Crowell & Moring attorneys discuss: (1) the historical factors and practical warning signs linking defective pricing and FCA actions; (2) the burdens and elements of proof in TINA and FCA litigations and how certain elements may overlap and even bolster defenses to both defective pricing and fraud actions; and (3) the procedural elements of TINA and FCA actions—such as stays of proceedings, evidentiary standards, and statutes of limitation—and where these factors may determine the outcomes in both defective pricing and fraud proceedings.
Contacts
Insights
Client Alert | 4 min read | 11.19.26
Since the choppy rollout of the U.S. Small Business Administration’s (SBA) Paycheck Protection Program (PPP) in the early days of the pandemic, the long wake of enforcement actions has followed in waves. First to fall were the bad actors, relying on falsified paperwork for employees and entities and using the loan proceeds to purchase Lamborghinis. Next were those loan recipients who fell victim to the complexities and changes in the loan eligibility requirements, many of which are grounded in the SBA’s existing complex regulations regarding affiliation. While government contractor PPP loan recipients have largely stayed out of the spotlight in reported settlements and False Claims Act (FCA) litigation to date, a recent enforcement action previews that a new wave is coming with government contractors as the target.
Client Alert | 1 min read | 11.19.26
GSA and DHS Launch E-Verify Enforcement Initiative Targeting Contractors
Client Alert | 3 min read | 11.17.26
CMS Final OPPS Rule Will Reduce Reimbursement for 340B Drugs
Client Alert | 9 min read | 11.17.26
Priorities and Prospects for AI Legislation in the New Congress


